Predicting factors for acute encephalopathy in febrile seizure children with SARS-CoV-2 omicron variant: a retrospective study

Ching Min Tang, Cheng Yen Kuo, Chen Wei Yen, Jainn Jim Lin, Yu Chia Hsieh, Shao Hsuan Hsia, Oi Wa Chan, En Pei Lee, Po Cheng Hung, Huei Shyong Wang, Kuang Lin Lin*, Cheng Hsun Chiu

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

1 Scopus citations

Abstract

Background: SARS-CoV-2 posed a threat to children during the early phase of Omicron wave because many patients presented with febrile seizures. The study aimed to investigate predicting factors for acute encephalopathy of children infected by SARS-CoV-2 Omicron variant presenting with febrile seizures. Methods: The retrospective study analyzed data from pediatric patients who visited the emergency department of Chang Gung Memorial Hospital in Taiwan between April and July 2022. We specifically focused on children with COVID-19 who presented with febrile seizures, collecting demographic, clinical, and laboratory data at the pediatric emergency department, as well as final discharge diagnoses. Subsequently, we conducted a comparative analysis of the clinical and laboratory characteristics between patients diagnosed with acute encephalopathy and those with other causes of febrile seizures. Results: Overall, 10,878 children were included, of which 260 patients presented with febrile seizures. Among them, 116 individuals tested positive for SARS-CoV-2 and of them, 14 subsequently developed acute encephalopathy (12%). Those with acute encephalopathy displayed distinctive features, including older age (5.1 vs. 2.6 years old), longer fever duration preceding the first seizure (1.6 vs. 0.9 days), cluster seizure (50% vs. 16.7%), status epilepticus (50% vs. 13.7%) and occurrences of bradycardia (26.8% vs. 0%) and hypotension (14.3% vs. 0%) in the encephalopathy group. Besides, the laboratory findings in the encephalopathy group are characterized by hyperglycemia (mean (95% CI) 146 mg/dL (95% CI 109–157) vs. 108 mg/dL (95% CI 103–114) and metabolic acidosis (mean (95% CI) pH 7.29(95% CI 7.22–7.36) vs. 7.39 (95%CI 7.37–7.41)). Conclusions: In pediatric patients with COVID-19-related febrile seizures, the occurrence of seizures beyond the first day of fever, bradycardia, clustered seizures, status epilepticus, hyperglycemia, and metabolic acidosis should raise concerns about acute encephalitis/encephalopathy. However, the highest body temperature and the severity of leukocytosis or C-reactive protein levels were not associated with poor outcomes.

Original languageEnglish
Article number211
Pages (from-to)211
JournalBMC Pediatrics
Volume24
Issue number1
DOIs
StatePublished - 25 03 2024
Externally publishedYes

Bibliographical note

© 2024. The Author(s).

Keywords

  • COVID-19
  • Encephalopathy
  • Febrile seizures
  • Pediatric
  • Predictive factor
  • SARS-CoV-2
  • Bradycardia/complications
  • COVID-19/complications
  • Humans
  • Status Epilepticus
  • Child, Preschool
  • Fever/etiology
  • Seizures/complications
  • Hyperglycemia/complications
  • Retrospective Studies
  • Seizures, Febrile/etiology
  • Brain Diseases/etiology
  • Acidosis
  • Child

Fingerprint

Dive into the research topics of 'Predicting factors for acute encephalopathy in febrile seizure children with SARS-CoV-2 omicron variant: a retrospective study'. Together they form a unique fingerprint.

Cite this